{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:53:28Z","timestamp":1784159608589,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00417-021-05536-y","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T07:02:41Z","timestamp":1641884561000},"page":"1941-1946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study"],"prefix":"10.1007","volume":"260","author":[{"given":"Julia","family":"Tau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Silvia","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"del Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"3","key":"5536_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/jcm9030761","volume":"9","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Och M, Kanclerz P, Leffler C, Moraes CG (2020) Primary open angle glaucoma and vascular risk factors: a review of population based studies from 1990 and 2019. J Clin Med 9(3):761. https:\/\/doi.org\/10.3390\/jcm9030761","journal-title":"J Clin Med"},{"issue":"7","key":"5536_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.4103\/1673-5374.235017","volume":"13","author":"NA Sharif","year":"2018","unstructured":"Sharif NA (2018) Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision. Neural Regen Res 13(7):1145\u20131150. https:\/\/doi.org\/10.4103\/1673-5374.235017","journal-title":"Neural Regen Res"},{"issue":"2","key":"5536_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2020.21899","volume":"325","author":"JD Stein","year":"2021","unstructured":"Stein JD, Khawaja AP, Weizer JS (2021) Glaucoma in adults-screening, diagnosis, and management: a Review. JAMA 325(2):164\u2013174. https:\/\/doi.org\/10.1001\/jama.2020.21899","journal-title":"JAMA"},{"issue":"13","key":"5536_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3238\/arztebl.2020.0225","volume":"117","author":"AK Schuster","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N (2020) The diagnosis and treatment of glaucoma. Dtsch Arztebl Int 117(13):225\u2013234. https:\/\/doi.org\/10.3238\/arztebl.2020.0225","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"5536_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/archopht.121.6.835","volume":"121","author":"Y Goto","year":"2003","unstructured":"Goto Y, Ibaraki N, Miyake K (2003) Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol. Arch Ophthalmol 121(6):835\u2013839. https:\/\/doi.org\/10.1001\/archopht.121.6.835","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"5536_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29(4):312\u2013334. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.03.001","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"5536_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/bjophthalmol-2017-311544","volume":"102","author":"DW Steven","year":"2018","unstructured":"Steven DW, Alaghband P, Lim KS (2018) Preservatives in glaucoma medication. Br J Ophthalmol 102(11):1497\u20131503. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311544","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"5536_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/17425255.2016.1209481","volume":"12","author":"A Aguayo Bonniard","year":"2016","unstructured":"Aguayo Bonniard A, Yeung JY, Chan CC, Birt CM (2016) Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opin Drug Metab Toxicol 12(11):1279\u20131289. https:\/\/doi.org\/10.1080\/17425255.2016.1209481","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"5536_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/15569527.2020.1787435","volume":"39","author":"L Sedlak","year":"2020","unstructured":"Sedlak L, Wojnar W, Zych M, Wygl\u0119dowska-Promie\u0144ska D (2020) Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film. Cutan Ocul Toxicol 39(3):260\u2013268. https:\/\/doi.org\/10.1080\/15569527.2020.1787435","journal-title":"Cutan Ocul Toxicol"},{"issue":"4","key":"5536_CR10","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1167\/iovs.16-20903","volume":"58","author":"S Datta","year":"2017","unstructured":"Datta S, Baudouin C, Brignole-Baudouin F, Denoyer A, Cortopassi GA (2017) The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells. Invest Ophthalmol Vis Sci 58(4):2406\u20132412. https:\/\/doi.org\/10.1167\/iovs.16-20903","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"5536_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/mi.2012.44","volume":"6","author":"JG Galletti","year":"2013","unstructured":"Galletti JG, Gabelloni ML, Morande PE, Sabbione F, Vermeulen ME, Treani AS, Giordano MS (2013) Benzalkonium chloride breaks down conjunctival immunological tolerance in a murine model. Mucosal Immunol 6(1):24\u201334. https:\/\/doi.org\/10.1038\/mi.2012.44","journal-title":"Mucosal Immunol"},{"issue":"9","key":"5536_CR12","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1167\/iovs.14-14075","volume":"55","author":"M Guzm\u00e1n","year":"2014","unstructured":"Guzm\u00e1n M, Sabbione F, Gabelloni ML, Vanzulli S, Trevani AS, Giordano MN, Galleti JG (2014) Restoring conjunctival tolerance by topical nuclear factor-\u03baB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice. Invest Ophthalmol Vis Sci 55(9):6116\u20136126. https:\/\/doi.org\/10.1167\/iovs.14-14075","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"5536_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/jop.2018.0040","volume":"34","author":"P Daull","year":"2018","unstructured":"Daull P, Raymond E, Feraille L, Garrigue JS (2018) Safety and tolerability of overdosed artificial tears by Abraded Rabbit Corneas. J Ocul Pharmacol Ther 34(10):670\u2013676. https:\/\/doi.org\/10.1089\/jop.2018.0040","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"5536_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/bjophthalmol-2019-314234","volume":"105","author":"V Murugesan","year":"2021","unstructured":"Murugesan V, Dwivedi R, Saini M, Gupta V, Dada T, Vivekanandhan S (2021) Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives. Br J Ophthalmol 105(1):141\u2013148. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314234","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"5536_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/jop.2019.0165","volume":"36","author":"K Kabashima","year":"2020","unstructured":"Kabashima K, Murakami A, Ebihara N (2020) Effects of benzalkonium chloride and preservative-free composition on the corneal epithelium cells. J Ocul Pharmacol Ther 36(9):672\u2013678. https:\/\/doi.org\/10.1089\/jop.2019.0165","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"5536_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1755-3768.2008.01250.x","volume":"86","author":"C Baudouin","year":"2008","unstructured":"Baudouin C (2008) Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol 86(7):716\u2013726. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01250.x","journal-title":"Acta Ophthalmol"},{"key":"5536_CR17","doi-asserted-by":"publisher","first-page":"696328","DOI":"10.1155\/2013\/696328","volume":"2013","author":"S Ka\u0161telan","year":"2013","unstructured":"Ka\u0161telan S, Tomi\u0107 M, Mete\u017eSoldo K, Salopek-Rabati\u0107 J (2013) How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int 2013:696328. https:\/\/doi.org\/10.1155\/2013\/696328","journal-title":"Biomed Res Int"},{"issue":"2","key":"5536_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.oftal.2017.07.012","volume":"93","author":"MC V\u00e9lez-G\u00f3mez","year":"2018","unstructured":"V\u00e9lez-G\u00f3mez MC, V\u00e1squez-Trespalacios EM (2018) Adherence to topical treatment of glaucoma, risk and protective factors: a review. Arch Soc Esp Oftalmol 93(2):87\u201392. https:\/\/doi.org\/10.1016\/j.oftal.2017.07.012","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"3","key":"5536_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","volume":"15","author":"JAP Gomes","year":"2017","unstructured":"Gomes JAP, Azar DT, Baudouin C, Efron N, Hirayama M, Horwath-Winter J, Kim T, Mehta JS, Messmer EM, Pepose JS, Sangwan VS, Weiner AL, Wilson SE, Wolffsohn JS (2017) TFOS DEWS II iatrogenic report. Ocul Surf 15(3):511\u201338. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.004","journal-title":"Ocul Surf"},{"key":"5536_CR20","doi-asserted-by":"publisher","unstructured":"Fogagnolo P, Torregrossa G, Tranchina L, Ferreras A, De Cill\u00e1 S, Labb\u00e9 A, Figus M, Ottobelli L, Rosetti L (2019) Tear film osmolarity, ocular surface disease and glaucoma: a review. Curr Med Chem 26(22):4241\u20134252. https:\/\/doi.org\/10.2174\/0929867326666190725160621","DOI":"10.2174\/0929867326666190725160621"},{"issue":"10","key":"5536_CR21","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1167\/iovs.03-0560","volume":"44","author":"Y Diebold","year":"2003","unstructured":"Diebold Y, Calonge M, De Salamanca AE, Callejo S, Corrales RM, S\u00e1ez V, Siemasko KF, Stern ME (2003) Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Investig Ophthalmol Vis Sci 44(10):4263\u201374. https:\/\/doi.org\/10.1167\/iovs.03-0560","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5536_CR22","doi-asserted-by":"publisher","DOI":"10.2174\/1871520621999201230202614","author":"Z Nozhat","year":"2020","unstructured":"Nozhat Z, Khalaji MS, Hedayati M, Kia SK (2020) Different methods for cell viability and proliferation assay: essential tools in pharmaceutical studies. Anticancer Agents Med Chem. https:\/\/doi.org\/10.2174\/1871520621999201230202614","journal-title":"Anticancer Agents Med Chem"},{"key":"5536_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/OPTH.S211611","volume":"13","author":"K Walsh","year":"2019","unstructured":"Walsh K, Jones L (2019) The use of preservatives in dry eye drops. Clin Ophthalmol 13:1409\u20131425. https:\/\/doi.org\/10.2147\/OPTH.S211611","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"5536_CR24","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.tiv.2010.02.001","volume":"24","author":"GM Yanochko","year":"2010","unstructured":"Yanochko GM, Khoh-Reiter S, Evans MG, Jessen BA (2010) Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells. Toxicol In Vitro 24(4):1324\u20131331. https:\/\/doi.org\/10.1016\/j.tiv.2010.02.001","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"5536_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5005\/jp-journals-10008-1130","volume":"7","author":"WC Stewart","year":"2013","unstructured":"Stewart WC, Oehler JC, Choplin NT, Markoff JI, Moster MR, Ichhpujani P, Nelson LA (2013) A comfort survey of timolol hemihydrate 0.5% solution once or twice daily vs timolol maleate in sorbate. J Curr Glaucoma Pract 7(1):11\u201316. https:\/\/doi.org\/10.5005\/jp-journals-10008-1130","journal-title":"J Curr Glaucoma Pract"},{"key":"5536_CR26","doi-asserted-by":"publisher","unstructured":"Khiev D, Mohamed ZA, Vichare R, Paulson R, Bhatia S, Mohapatra S, Lobo GP, Valapala M, Kerur N, Passaglia CL, Mohapatra SS, Biswal MR (2021) Emerging nano-formulations and nanomedicines applications for ocular drug delivery. Nanomaterials (Basel) 11(1):173. https:\/\/doi.org\/10.3390\/nano11010173","DOI":"10.3390\/nano11010173"},{"issue":"3","key":"5536_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","volume":"7","author":"Y Weng","year":"2017","unstructured":"Weng Y, Liu J, Jin S, Gup W, Liang X, Hu Z (2017) Nanotechnology-based strategies for treatment of ocular disease. Acta Pharmaceutica Sinica B 7(3):281\u2013291","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"5536_CR28","doi-asserted-by":"publisher","unstructured":"Casiraghi JF, Grigera D, Peyret AJ, del Papa M, Passerini MS.Re:GEN Open.Jun 2021.110\u2013116. https:\/\/doi.org\/10.1089\/regen.2021.0018","DOI":"10.1089\/regen.2021.0018"},{"key":"5536_CR29","first-page":"394","volume":"14","author":"E Brasnu","year":"2008","unstructured":"Brasnu E, Brignole-Baudouin F, Riancho L, Warnet JM, Baudouin C (2008) Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines. Mol Vis 14:394\u2013402","journal-title":"Mol Vis"},{"issue":"4","key":"5536_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/02713680801971857","volume":"33","author":"E Brasnu","year":"2008","unstructured":"Brasnu E, Brignole-Baudouin F, Riancho L, Guenoun JM, Warnet JM, Baudouin C (2008) In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res 33(4):303\u2013312. https:\/\/doi.org\/10.1080\/02713680801971857","journal-title":"Curr Eye Res"},{"issue":"2","key":"5536_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/02713683.2011.626909","volume":"37","author":"P Pellinen","year":"2012","unstructured":"Pellinen P, Huhtala A, Tolonen A, Lokkila J, M\u00e4enp\u00e4\u00e4 J, Uusitalo H (2012) The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo. Curr Eye Res 37(2):145\u2013154. https:\/\/doi.org\/10.3109\/02713683.2011.626909","journal-title":"Curr Eye Res"},{"issue":"1","key":"5536_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/02713683.2014.915574","volume":"40","author":"A Labb\u00e9","year":"2015","unstructured":"Labb\u00e9 A, Gabison E, Brignole-Baudouin F, Riancho L, Menashi S, Baudouin C (2015) Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments. Curr Eye Res 40(1):40\u201347. https:\/\/doi.org\/10.3109\/02713683.2014.915574","journal-title":"Curr Eye Res"},{"issue":"12","key":"5536_CR33","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1167\/iovs.05-0776","volume":"46","author":"JM Guenoun","year":"2005","unstructured":"Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F (2005) In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 46(12):4594\u20134599. https:\/\/doi.org\/10.1167\/iovs.05-0776","journal-title":"Invest Ophthalmol Vis Sci."}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05536-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05536-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T10:05:32Z","timestamp":1651485932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05536-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5536"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05536-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}